- Home
- VIVS vs PET Comparison
VIVS vs PET Comparison
Compare VIVS & PET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVS
- PET
- Stock Information
- Founded
- VIVS 2007
- PET 2015
- Country
- VIVS United States
- PET United States
- Employees
- VIVS N/A
- PET N/A
- Industry
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- PET EDP Services
- Sector
- VIVS Health Care
- PET Technology
- Exchange
- VIVS Nasdaq
- PET Nasdaq
- Market Cap
- VIVS 5.0M
- PET 5.9M
- IPO Year
- VIVS N/A
- PET N/A
- Fundamental
- Price
- VIVS $2.21
- PET $0.12
- Analyst Decision
- VIVS
- PET Strong Buy
- Analyst Count
- VIVS 0
- PET 2
- Target Price
- VIVS N/A
- PET $4.50
- AVG Volume (30 Days)
- VIVS 70.9K
- PET 18.3M
- Earning Date
- VIVS 08-05-2025
- PET 08-06-2025
- Dividend Yield
- VIVS N/A
- PET N/A
- EPS Growth
- VIVS N/A
- PET N/A
- EPS
- VIVS N/A
- PET N/A
- Revenue
- VIVS $144,000.00
- PET $62,453,000.00
- Revenue This Year
- VIVS $42.38
- PET $7.87
- Revenue Next Year
- VIVS $15.42
- PET $122.23
- P/E Ratio
- VIVS N/A
- PET N/A
- Revenue Growth
- VIVS 32.11
- PET N/A
- 52 Week Low
- VIVS $1.41
- PET $0.08
- 52 Week High
- VIVS $21.96
- PET $1.28
- Technical
- Relative Strength Index (RSI)
- VIVS N/A
- PET 44.47
- Support Level
- VIVS N/A
- PET $0.11
- Resistance Level
- VIVS N/A
- PET $0.14
- Average True Range (ATR)
- VIVS 0.00
- PET 0.03
- MACD
- VIVS 0.00
- PET -0.00
- Stochastic Oscillator
- VIVS 0.00
- PET 8.20
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
About PET Wag! Group Co.
Wag Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent Pet Caregivers to connect with pet parents. The platform allows pet parents to make pet service requests in the platform, which can then be fulfilled by Pet Caregivers. Wag supports dog walking, pet sitting, pet boarding, drop-in visits at the pet parent's home, advice from licensed pet experts, training services, pet insurance comparison tools and pet wellness plans.